PubMed COVID-19 Clinical Care
3111 - 3120 of 5136 results found
A randomized controlled trial examining a Tranquil sitting intervention compatible with Confucian values
Description
INTRODUCTION: During the COVID-19 pandemic in China, the silent management (Lockdown) policy has caused severe sleep problems for university students. Long-term isolation may further deteriorate sleep quality, and it requires practical interventions
A pipeline for the retrieval and extraction of domain-specific information with application to COVID-19 immune signatures
Description
CONCLUSIONS: Our results demonstrate the efficacy of using a SVM classifier with document embeddings of the title and abstract, to retrieve papers with domain-specific information, even when that information is rarely present in the abstract
A new group-based online job interview training program using computer graphics robots for individuals with autism spectrum disorders
Description
INTRODUCTION: Job interviews are a major barrier to employment for individuals with autism spectrum disorders (ASD). During the coronavirus pandemic, establishing online job interview training at home was indispensable. However, many hurdles prevent
Artificial Intelligence, Machine Learning and Deep Learning: Potential Resources for the Infection Clinician
Description
CONCLUSIONS: Interest in and development of AI-based tools for infection research and management are undoubtedly gaining pace, although the real-world clinical utility to date appears much more modest.
A genetic basis for asymptomatic SARS-CoV-2 infection
Description
No abstract
Angiotensin I-converting enzyme type 2 expression is increased in pancreatic islets of type 2 diabetic donors
Description
CONCLUSIONS: Higher ACE2 expression in T2D islets might increase their susceptibility to SARS-CoV-2 infection during COVID-19 in T2D patients, thus worsening glycometabolic outcomes and disease severity.
A novel biosensor based on a bio-barcode for the detection of Mycobacterium tuberculosis
Description
Tuberculosis (TB), the second (after COVID-19) deadliest infectious killer, is a chronic infectious disease caused by infection with Mycobacterium tuberculosis (M.T.), where early diagnosis and management are the key to containing the condition. Here
A deep learning-based drug repurposing screening and validation for anti-SARS-CoV-2 compounds by targeting the cell entry mechanism
Description
The recent outbreak of Corona Virus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been a severe threat to the global public health and economy, however, effective drugs to treat COVID-19 are still
Activation of SARS-CoV-2 by trypsin-like proteases in the clinical specimens of patients with COVID-19
Description
SARS-CoV-2 enters host cells through the angiotensin converting enzyme 2 (ACE2) receptor and/or transmembrane protease, serine 2 (TMPRSS2). In this study, we investigated whether proteases increased SARS-CoV-2 infectivity using pseudotyped viruses
